Last update 21 Nov 2024
Allogeneic dental pulp mesenchymal stem cell therapy (Beijing SH Bio-Tech Corporation/Utooth Biological Technology)
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Mesenchymal stem cell therapy |
Synonyms Human Dental Pulp Mesenchymal Stem Cell (Beijing Sh Biotechnology) |
Target- |
Mechanism Cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
4
Clinical Trials associated with Allogeneic dental pulp mesenchymal stem cell therapy (Beijing SH Bio-Tech Corporation/Utooth Biological Technology)A Phase 2, Randomized, Double-blind, Parallel, Placebo-controlled Study to Evaluate Efficacy and Safety of Local Injection of Human Dental Pulp Mesenchymal Stem Cells for the Treatment of Chronic Periodontitis Patients.
评价局部注射人牙髓间充质干细胞治疗慢性牙周炎患者的有效性和安全性的随机、双盲、平行、安慰剂对照的II期临床试验
[Translation] A randomized, double-blind, parallel, placebo-controlled phase II clinical trial to evaluate the efficacy and safety of local injection of human dental pulp mesenchymal stem cells in the treatment of patients with chronic periodontitis
Wrinkle-improving effect of an all-in-one gel containing "Immortalized Human Tooth Pulp Stem Cell Conditioned Media" and "Human Cord Blood Stem Cell Conditioned Media" : single blinded study - Wrinkle-improving effect of an all-in-one gel containing "Immortalized Human Tooth Pulp Stem Cell Conditioned Media" and "Human Cord Blood Stem Cell Conditioned Media"
100 Clinical Results associated with Allogeneic dental pulp mesenchymal stem cell therapy (Beijing SH Bio-Tech Corporation/Utooth Biological Technology)
Login to view more data
100 Translational Medicine associated with Allogeneic dental pulp mesenchymal stem cell therapy (Beijing SH Bio-Tech Corporation/Utooth Biological Technology)
Login to view more data
100 Patents (Medical) associated with Allogeneic dental pulp mesenchymal stem cell therapy (Beijing SH Bio-Tech Corporation/Utooth Biological Technology)
Login to view more data
100 Deals associated with Allogeneic dental pulp mesenchymal stem cell therapy (Beijing SH Bio-Tech Corporation/Utooth Biological Technology)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Chronic Periodontitis | Phase 2 | CN | 13 Nov 2023 | |
| Chronic Periodontitis | Phase 2 | CN | 13 Nov 2023 | |
| Intrabony periodontal defect | Phase 1 | CN | 31 Jul 2021 | |
| Intrabony periodontal defect | Phase 1 | CN | 31 Jul 2021 | |
| Psoriasis | IND Application | CN | 30 Jan 2022 | |
| Paraquat Lung | Preclinical | CN | 30 Jan 2022 | |
| Pulmonary Disease, Chronic Obstructive | Preclinical | CN | 30 Jan 2022 | |
| Pulmonary Fibrosis | Preclinical | CN | 30 Jan 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free